# EZETIMIBE AND SIMVASTATIN
> **ANDA202968** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2017-04-26
## Drug
- **FDA Application Number:** ANDA202968
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EZETIMIBE AND SIMVASTATIN
- **Generic name:** Ezetimibe
- **Active ingredients:** EZETIMIBE; SIMVASTATIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** WATSON LABS INC
- **First approval:** 2017-04-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202968)
---
*MORVS · CC0 1.0*